FINWIRES · TerminalLIVE
FINWIRES

美国石油市场动态:受美伊谈判和霍尔木兹海峡重新开放希望提振,期货价格下跌

By

-- 周五盘后交易中,原油期货价格回落,此前有报道称,伊朗已通过巴基斯坦调解人向美国提交了一份新的和平方案,缓解了人们对中东地区原油供应进一步中断的担忧,并提振了人们对霍尔木兹海峡重新开放的希望。 近月西德克萨斯中质原油期货下跌2.45%,至每桶102.50美元;布伦特原油期货下跌1.21%,至每桶109.06美元。 周五,特朗普总统致函国会,解释说由于已达成停火协议,他无需获得国会授权即可在伊朗开展军事行动,尽管本周冲突已持续60天。 “2026年4月7日,我下令停火两周。此后停火期限已延长。自2026年4月7日以来,美伊军队之间未发生交火。始于2026年2月28日的敌对行动已经结束。”特朗普在致众议院和参议院的信中写道。 特朗普表示,尽管美国对伊朗的军事行动取得了成功,并且为维护和平做出了持续努力,但德黑兰对美国及其军队构成的威胁依然重大。 伊朗伊斯兰革命卫队海军司令部表示,将在阿拉伯海和霍尔木兹海峡伊朗近岸水域执行“新规则”,使其成为“该地区安全与繁荣的源泉”。 据媒体报道,伊朗于周四向巴基斯坦调解人提交了最新的与美国谈判方案。与此同时,特朗普威胁称,在幕后外交斡旋以结束中东冲突的同时,他将继续封锁伊朗港口。 据报道,美国周一提交了一份修正案清单,旨在将核问题重新纳入正在讨论的协议中。其中一项修正案要求伊朗承诺不试图转移任何浓缩铀。 周五,美国财政部外国资产控制办公室表示,即使船只以慈善捐款的形式向伊朗非政府组织支付通行费,美国财政部也可以对向伊朗支付通行费以确保安全通过霍尔木兹海峡的船只实施制裁。 财政部表示,伊朗要求支付通行费的方式可能包括法定货币、数字资产、抵消交易、非正式互换,或向伊朗红新月会、伊朗最高行政机构(Bonyad Mostazafan)或伊朗大使馆账户捐赠。 据Kpler报道,4月30日,霍尔木兹海峡的通行量比前一天减少了一半,仅剩7艘船只通过,其中4艘为商业船只,3艘为非商业船只。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Cincinnati Financial Corp.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target price by $7 to $185, valuing CINF shares (currently yielding 2%) at 20x our 2027 operating EPS estimate of $9.15 (raised by $0.10) and at 21.5x our 2026 EPS estimate of $8.60 (raised by $0.10), versus its five-year average forward multiple of 21x and peer average. CINF posted Q1 operating EPS of $2.10 versus a $0.24 operating loss per share a year ago, matching our estimate and topping the $1.94 consensus view, amid 12% higher operating revenues due to 11% premium growth and 14% higher net investment income, with written premium growth of 7% likely at the upper end of peer averages. We believe CINF's competitive strengths include its facile underwriting style and ability to allocate underwriting capital to areas with the most promising fundamentals, positioning it well despite increasingly competitive market conditions. CINF's ability to consistently produce above-peer growth and underwriting profitability will support the shares' premium valuation versus peers, in our view.

$CINF
Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Linde Plc

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target by $48 to $537, using a P/E of 27.1x, equal to LIN's average forward P/E over the last three years. We raise our 2026 EPS estimate by $0.05 to $18.03 and 2027 by $0.26 to $19.81. LIN reported Q1 adj. EPS of $4.33, beating consensus by $0.06, with 30% operating margins and 24% ROC demonstrating the resilience of its business model. Management raised the low end of full-year guidance to $17.60-$17.90 (7%-9% growth), citing confidence despite geopolitical headwinds. The $7.1B project backlog should reach $8B+ by year-end, driven by Electronics projects supporting AI chip manufacturing. Americas volumes grew 2% Y/Y with double-digit hardgoods growth, though EMEA remains challenged by weak industrial activity. Commercial space is emerging as a significant growth driver, with aerospace sales up double-digits. Helium supply tightness presents upside opportunity beyond guidance. We think shares are fully valued at 25.6x our 2027 EPS estimate, limiting upside potential in the near term.

$LIN
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Silgan Holdings Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $13 to $46, based on an EV/EBITDA of 8.9x our 2026 EBITDA estimate, in line with SLGN's three-year average multiple. We increase our 2026 EPS estimate by $0.05 to $3.90 and raise 2027's by $0.05 to $4.20. Metal containers started the year strong, up 2% Y/Y, with pet food product volume up 11%. Management continues to see a long runway for growth in the fragrance, beauty, and health care category now that it is fully integrated into the Weener portfolio. We anticipate further product launches and customer partnerships in 2027, driving growth in this space. Dispensing and specialty closures headwinds are due to higher-cost inventory with volumes adversely affected by severe weather events in North America. Management also noted that volume is likely to improve in 2H 2026 after securing new business wins that have yet to be commercialized but were secured earlier this year.

$SLGN